深入研究新冠疫苗接种引起的过敏反应：mRNA疫苗在肥大细胞疾病中是否安全？ - Suppr

Suppr

超能文献

Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?

作者信息

Azenha Rama T, Álvarez-Twose I

机构信息

Serviço de Imunoalergologia, Centro Hospitalar Universitário São João, Porto, Portugal.

Serviço de Imunologia, Faculdade de Medicina da Universidade do Porto, Portugal.

出版信息

J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):193-195. doi: 10.18176/jiaci.0680. Epub 2021 Feb 12.

DOI:10.18176/jiaci.0680

PMID:33574015

Abstract

摘要

相似文献

Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?

J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):193-195. doi: 10.18176/jiaci.0680. Epub 2021 Feb 12.

Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.

J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):180-181. doi: 10.18176/jiaci.0683. Epub 2021 Mar 2.

Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.

Mol Ther. 2021 Mar 3;29(3):898-900. doi: 10.1016/j.ymthe.2021.01.030. Epub 2021 Feb 5.

mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.

J Allergy Clin Immunol. 2021 Mar;147(3):877-878. doi: 10.1016/j.jaci.2021.01.004. Epub 2021 Jan 19.

The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.

J Investig Allergol Clin Immunol. 2021 Feb 17;31(1):89-91. doi: 10.18176/jiaci.0665. Epub 2020 Jan 4.

Maintaining Safety with SARS-CoV-2 Vaccines.

N Engl J Med. 2021 Feb 18;384(7):643-649. doi: 10.1056/NEJMra2035343. Epub 2020 Dec 30.

Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation.

Clin Immunol. 2021 Jun;227:108748. doi: 10.1016/j.clim.2021.108748. Epub 2021 Apr 28.

COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.

Front Immunol. 2021 May 21;12:669010. doi: 10.3389/fimmu.2021.669010. eCollection 2021.

Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy.

Therapie. 2021 Jul-Aug;76(4):365-367. doi: 10.1016/j.therap.2021.03.005. Epub 2021 Apr 2.

COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.

S Afr Med J. 2021 Feb 8;111(4):291-294. doi: 10.7196/SAMJ.2021.v111i4.15576.

引用本文的文献

Occurrence of erythema multiforme following COVID-19 vaccination: a review.

Clin Exp Vaccine Res. 2023 Apr;12(2):87-96. doi: 10.7774/cevr.2023.12.2.87. Epub 2023 Apr 30.

Safety of COVID-19 vaccination in patients with clonal mast cell disorders.

J Allergy Clin Immunol Pract. 2022 May;10(5):1374-1376.e3. doi: 10.1016/j.jaip.2022.01.030. Epub 2022 Feb 1.

Cutaneous and Allergic reactions due to COVID-19 vaccinations: A review.

J Cosmet Dermatol. 2022 Jan;21(1):4-12. doi: 10.1111/jocd.14613. Epub 2021 Nov 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Delving Into COVID-19 Vaccination-Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?

J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):193-195. doi: 10.18176/jiaci.0680. Epub 2021 Feb 12.

Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.

J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):180-181. doi: 10.18176/jiaci.0683. Epub 2021 Mar 2.

Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines.

Mol Ther. 2021 Mar 3;29(3):898-900. doi: 10.1016/j.ymthe.2021.01.030. Epub 2021 Feb 5.

mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis.

J Allergy Clin Immunol. 2021 Mar;147(3):877-878. doi: 10.1016/j.jaci.2021.01.004. Epub 2021 Jan 19.

The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.

J Investig Allergol Clin Immunol. 2021 Feb 17;31(1):89-91. doi: 10.18176/jiaci.0665. Epub 2020 Jan 4.

Maintaining Safety with SARS-CoV-2 Vaccines.

N Engl J Med. 2021 Feb 18;384(7):643-649. doi: 10.1056/NEJMra2035343. Epub 2020 Dec 30.

Anaphylaxis associated with the mRNA COVID-19 vaccines: Approach to allergy investigation.

Clin Immunol. 2021 Jun;227:108748. doi: 10.1016/j.clim.2021.108748. Epub 2021 Apr 28.

COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.

Front Immunol. 2021 May 21;12:669010. doi: 10.3389/fimmu.2021.669010. eCollection 2021.

Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy.

Therapie. 2021 Jul-Aug;76(4):365-367. doi: 10.1016/j.therap.2021.03.005. Epub 2021 Apr 2.

COVID-19 vaccination: Recommendations for management of patients with allergy or immune-based diseases.

S Afr Med J. 2021 Feb 8;111(4):291-294. doi: 10.7196/SAMJ.2021.v111i4.15576.

引用本文的文献

Occurrence of erythema multiforme following COVID-19 vaccination: a review.

Clin Exp Vaccine Res. 2023 Apr;12(2):87-96. doi: 10.7774/cevr.2023.12.2.87. Epub 2023 Apr 30.

Safety of COVID-19 vaccination in patients with clonal mast cell disorders.

J Allergy Clin Immunol Pract. 2022 May;10(5):1374-1376.e3. doi: 10.1016/j.jaip.2022.01.030. Epub 2022 Feb 1.

Cutaneous and Allergic reactions due to COVID-19 vaccinations: A review.

J Cosmet Dermatol. 2022 Jan;21(1):4-12. doi: 10.1111/jocd.14613. Epub 2021 Nov 17.